Global Antibody Drug Conjugate Market Research Report 2016


Report ID : RNR-26193 Category : Pharma Healthcare Published Date : 14-Oct
Publisher : QYResearch Pages : 111 Format : PDF
Notes:
Production, means the output of Antibody Drug Conjugate
Revenue, means the sales value of Antibody Drug Conjugate

This report studies Antibody Drug Conjugate in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
    Seattle Genetics/Takeda
    Roche
    ImmunoGen
    Immunomedics
    Pfizer
    Celldex Therapeutics
    Millennium Pharmaceuticals
    Bayer HealthCare
    Mersana Therapeutics
    Heidelberg Pharma
    Oxford BioTherapeutics
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Antibody Drug Conjugate in these regions, from 2011 to 2021 (forecast), like
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
    Adcetris
    Kadcyla
    Type III
Split by application, this report focuses on consumption, market share and growth rate of Antibody Drug Conjugate in each application, can be divided into
    Application 1
    Application 2
    Application 3

Table of Contents

Global Antibody Drug Conjugate Market Research Report 2016
1 Antibody Drug Conjugate Market Overview
    1.1 Product Overview and Scope of Antibody Drug Conjugate
    1.2 Antibody Drug Conjugate Segment by Type
        1.2.1 Global Production Market Share of Antibody Drug Conjugate by Type in 2015
        1.2.2 Adcetris
        1.2.3 Kadcyla
        1.2.4 Type III
    1.3 Antibody Drug Conjugate Segment by Application
        1.3.1 Antibody Drug Conjugate Consumption Market Share by Application in 2015
        1.3.2 Application 1
        1.3.3 Application 2
        1.3.4 Application 3
    1.4 Antibody Drug Conjugate Market by Region
        1.4.1 North America Status and Prospect (2011-2021)
        1.4.2 Europe Status and Prospect (2011-2021)
        1.4.3 China Status and Prospect (2011-2021)
        1.4.4 Japan Status and Prospect (2011-2021)
        1.4.5 Southeast Asia Status and Prospect (2011-2021)
        1.4.6 India Status and Prospect (2011-2021)
    1.5 Global Market Size (Value) of Antibody Drug Conjugate (2011-2021)

2 Global Antibody Drug Conjugate Market Competition by Manufacturers
    2.1 Global Antibody Drug Conjugate Production and Share by Manufacturers (2015 and 2016)
    2.2 Global Antibody Drug Conjugate Revenue and Share by Manufacturers (2015 and 2016)
    2.3 Global Antibody Drug Conjugate Average Price by Manufacturers (2015 and 2016)
    2.4 Manufacturers Antibody Drug Conjugate Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Antibody Drug Conjugate Market Competitive Situation and Trends
        2.5.1 Antibody Drug Conjugate Market Concentration Rate
        2.5.2 Antibody Drug Conjugate Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Antibody Drug Conjugate Production, Revenue (Value) by Region (2011-2016)
    3.1 Global Antibody Drug Conjugate Production and Market Share by Region (2011-2016)
    3.2 Global Antibody Drug Conjugate Revenue (Value) and Market Share by Region (2011-2016)
    3.3 Global Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2011-2016)
    3.4 North America Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2011-2016)
    3.5 Europe Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2011-2016)
    3.6 China Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2011-2016)
    3.7 Japan Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2011-2016)
    3.8 Southeast Asia Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2011-2016)
    3.9 India Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Antibody Drug Conjugate Supply (Production), Consumption, Export, Import by Regions (2011-2016)
    4.1 Global Antibody Drug Conjugate Consumption by Regions (2011-2016)
    4.2 North America Antibody Drug Conjugate Production, Consumption, Export, Import by Regions (2011-2016)
    4.3 Europe Antibody Drug Conjugate Production, Consumption, Export, Import by Regions (2011-2016)
    4.4 China Antibody Drug Conjugate Production, Consumption, Export, Import by Regions (2011-2016)
    4.5 Japan Antibody Drug Conjugate Production, Consumption, Export, Import by Regions (2011-2016)
    4.6 Southeast Asia Antibody Drug Conjugate Production, Consumption, Export, Import by Regions (2011-2016)
    4.7 India Antibody Drug Conjugate Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Antibody Drug Conjugate Production, Revenue (Value), Price Trend by Type
    5.1 Global Antibody Drug Conjugate Production and Market Share by Type (2011-2016)
    5.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2011-2016)
    5.3 Global Antibody Drug Conjugate Price by Type (2011-2016)
    5.4 Global Antibody Drug Conjugate Production Growth by Type (2011-2016)

6 Global Antibody Drug Conjugate Market Analysis by Application
    6.1 Global Antibody Drug Conjugate Consumption and Market Share by Application (2011-2016)
    6.2 Global Antibody Drug Conjugate Consumption Growth Rate by Application (2011-2016)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Antibody Drug Conjugate Manufacturers Profiles/Analysis
    7.1 Seattle Genetics/Takeda
        7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.1.2 Antibody Drug Conjugate Product Type, Application and Specification
            7.1.2.1 Type I
            7.1.2.2 Type II
        7.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.1.4 Main Business/Business Overview
    7.2 Roche
        7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.2.2 Antibody Drug Conjugate Product Type, Application and Specification
            7.2.2.1 Type I
            7.2.2.2 Type II
        7.2.3 Roche Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.2.4 Main Business/Business Overview
    7.3 ImmunoGen
        7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.3.2 Antibody Drug Conjugate Product Type, Application and Specification
            7.3.2.1 Type I
            7.3.2.2 Type II
        7.3.3 ImmunoGen Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.3.4 Main Business/Business Overview
    7.4 Immunomedics
        7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.4.2 Antibody Drug Conjugate Product Type, Application and Specification
            7.4.2.1 Type I
            7.4.2.2 Type II
        7.4.3 Immunomedics Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.4.4 Main Business/Business Overview
    7.5 Pfizer
        7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.5.2 Antibody Drug Conjugate Product Type, Application and Specification
            7.5.2.1 Type I
            7.5.2.2 Type II
        7.5.3 Pfizer Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.5.4 Main Business/Business Overview
    7.6 Celldex Therapeutics
        7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.6.2 Antibody Drug Conjugate Product Type, Application and Specification
            7.6.2.1 Type I
            7.6.2.2 Type II
        7.6.3 Celldex Therapeutics Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.6.4 Main Business/Business Overview
    7.7 Millennium Pharmaceuticals
        7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.7.2 Antibody Drug Conjugate Product Type, Application and Specification
            7.7.2.1 Type I
            7.7.2.2 Type II
        7.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.7.4 Main Business/Business Overview
    7.8 Bayer HealthCare
        7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.8.2 Antibody Drug Conjugate Product Type, Application and Specification
            7.8.2.1 Type I
            7.8.2.2 Type II
        7.8.3 Bayer HealthCare Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.8.4 Main Business/Business Overview
    7.9 Mersana Therapeutics
        7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.9.2 Antibody Drug Conjugate Product Type, Application and Specification
            7.9.2.1 Type I
            7.9.2.2 Type II
        7.9.3 Mersana Therapeutics Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.9.4 Main Business/Business Overview
    7.10 Heidelberg Pharma
        7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.10.2 Antibody Drug Conjugate Product Type, Application and Specification
            7.10.2.1 Type I
            7.10.2.2 Type II
        7.10.3 Heidelberg Pharma Antibody Drug Conjugate Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.10.4 Main Business/Business Overview
    7.11 Oxford BioTherapeutics

8 Antibody Drug Conjugate Manufacturing Cost Analysis
    8.1 Antibody Drug Conjugate Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Antibody Drug Conjugate

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Antibody Drug Conjugate Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Antibody Drug Conjugate Market Forecast (2016-2021)
    12.1 Global Antibody Drug Conjugate Production, Revenue Forecast (2016-2021)
    12.2 Global Antibody Drug Conjugate Production, Consumption Forecast by Regions (2016-2021)
    12.3 Global Antibody Drug Conjugate Production Forecast by Type (2016-2021)
    12.4 Global Antibody Drug Conjugate Consumption Forecast by Application (2016-2021)
    12.5 Antibody Drug Conjugate Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
    Author List
    Disclosure Section
    Research Methodology
    Data Source
    China Disclaimer